Telix Gross Profit vs Net Income From Continuing Ops Analysis

TLX Stock   18.20  0.39  2.10%   
Telix Pharmaceuticals financial indicator trend analysis is much more than just breaking down Telix Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Telix Pharmaceuticals is a good investment. Please check the relationship between Telix Pharmaceuticals Gross Profit and its Net Income From Continuing Ops accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telix Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Gross Profit vs Net Income From Continuing Ops

Gross Profit vs Net Income From Continuing Ops Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Telix Pharmaceuticals Gross Profit account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have strong relationship.
The correlation between Telix Pharmaceuticals' Gross Profit and Net Income From Continuing Ops is 0.72. Overlapping area represents the amount of variation of Gross Profit that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of Telix Pharmaceuticals Limited, assuming nothing else is changed. The correlation between historical values of Telix Pharmaceuticals' Gross Profit and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Gross Profit of Telix Pharmaceuticals Limited are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Gross Profit i.e., Telix Pharmaceuticals' Gross Profit and Net Income From Continuing Ops go up and down completely randomly.

Correlation Coefficient

0.72
Relationship DirectionPositive 
Relationship StrengthSignificant

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Telix Pharmaceuticals Limited minus its cost of goods sold. It is profit before Telix Pharmaceuticals operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Net Income From Continuing Ops

Most indicators from Telix Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Telix Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telix Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Selling General Administrative is likely to rise to about 95.4 M in 2025, despite the fact that Tax Provision is likely to grow to (2.3 M).
 2022 2023 2024 2025 (projected)
Interest Expense6.4M13.1M15.1M15.9M
Depreciation And Amortization228.5K6.7M6.1M6.4M

Telix Pharmaceuticals fundamental ratios Correlations

0.930.910.980.990.98-0.920.980.980.990.980.920.920.950.950.970.510.991.0-0.280.990.97-0.9-0.420.990.97
0.930.950.970.910.97-0.780.960.880.920.880.750.740.810.980.980.270.930.93-0.080.90.93-0.79-0.390.950.94
0.910.950.950.910.94-0.70.940.820.930.820.690.710.760.970.970.280.90.89-0.140.860.84-0.7-0.310.930.95
0.980.970.950.951.0-0.840.990.930.980.930.840.840.890.991.00.410.980.97-0.210.960.96-0.87-0.390.990.99
0.990.910.910.950.96-0.920.950.980.980.980.890.890.910.930.960.470.960.99-0.270.960.93-0.85-0.40.970.93
0.980.970.941.00.96-0.860.990.940.980.940.860.850.90.990.990.420.980.98-0.240.970.97-0.88-0.390.990.98
-0.92-0.78-0.7-0.84-0.92-0.86-0.85-0.98-0.89-0.98-0.95-0.93-0.94-0.78-0.83-0.6-0.91-0.940.37-0.94-0.910.930.46-0.88-0.81
0.980.960.940.990.950.99-0.850.930.990.930.870.870.920.980.980.460.990.97-0.20.970.96-0.89-0.431.00.99
0.980.880.820.930.980.94-0.980.930.951.00.950.940.960.880.920.530.960.99-0.320.980.96-0.92-0.450.950.9
0.990.920.930.980.980.98-0.890.990.950.950.90.910.940.950.970.510.990.98-0.270.980.95-0.88-0.40.990.98
0.980.880.820.930.980.94-0.980.931.00.950.950.940.960.880.920.530.960.99-0.320.980.96-0.92-0.450.950.9
0.920.750.690.840.890.86-0.950.870.950.90.950.990.990.770.810.640.930.93-0.390.950.91-0.95-0.530.890.85
0.920.740.710.840.890.85-0.930.870.940.910.940.990.990.770.820.610.920.92-0.430.950.89-0.94-0.510.880.85
0.950.810.760.890.910.9-0.940.920.960.940.960.990.990.840.870.610.960.95-0.380.980.94-0.96-0.50.930.9
0.950.980.970.990.930.99-0.780.980.880.950.880.770.770.840.990.370.950.94-0.170.930.94-0.82-0.330.980.98
0.970.980.971.00.960.99-0.830.980.920.970.920.810.820.870.990.360.970.96-0.230.950.95-0.83-0.350.990.98
0.510.270.280.410.470.42-0.60.460.530.510.530.640.610.610.370.360.520.51-0.220.540.47-0.63-0.240.470.44
0.990.930.90.980.960.98-0.910.990.960.990.960.930.920.960.950.970.520.99-0.30.990.98-0.93-0.410.990.98
1.00.930.890.970.990.98-0.940.970.990.980.990.930.920.950.940.960.510.99-0.280.990.98-0.92-0.440.990.95
-0.28-0.08-0.14-0.21-0.27-0.240.37-0.2-0.32-0.27-0.32-0.39-0.43-0.38-0.17-0.23-0.22-0.3-0.28-0.31-0.280.33-0.17-0.24-0.23
0.990.90.860.960.960.97-0.940.970.980.980.980.950.950.980.930.950.540.990.99-0.310.98-0.95-0.450.980.95
0.970.930.840.960.930.97-0.910.960.960.950.960.910.890.940.940.950.470.980.98-0.280.98-0.94-0.410.980.95
-0.9-0.79-0.7-0.87-0.85-0.880.93-0.89-0.92-0.88-0.92-0.95-0.94-0.96-0.82-0.83-0.63-0.93-0.920.33-0.95-0.940.53-0.9-0.87
-0.42-0.39-0.31-0.39-0.4-0.390.46-0.43-0.45-0.4-0.45-0.53-0.51-0.5-0.33-0.35-0.24-0.41-0.44-0.17-0.45-0.410.53-0.42-0.39
0.990.950.930.990.970.99-0.881.00.950.990.950.890.880.930.980.990.470.990.99-0.240.980.98-0.9-0.420.99
0.970.940.950.990.930.98-0.810.990.90.980.90.850.850.90.980.980.440.980.95-0.230.950.95-0.87-0.390.99
Click cells to compare fundamentals

Telix Pharmaceuticals Account Relationship Matchups

Telix Pharmaceuticals fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets157.8M109.8M255.4M398.3M458.0M480.9M
Short Long Term Debt Total2.2M2.5M10.4M17.4M20.1M21.1M
Other Current Liab6.3M6.1M4.9M123.0M141.5M148.5M
Total Current Liabilities20.0M38.0M85.6M157.4M181.0M190.1M
Total Stockholder Equity79.0M2.2M80.0M148.9M171.2M179.8M
Property Plant And Equipment Net4.8M6.3M18.8M30.5M35.1M36.8M
Net Debt(75.7M)(19.5M)(105.9M)(105.8M)(95.2M)(90.5M)
Accounts Payable5.8M11.9M16.8M32.8M37.8M39.7M
Cash77.9M22.0M116.3M123.2M141.7M148.8M
Non Current Assets Total64.2M62.3M82.1M173.5M199.5M209.4M
Cash And Short Term Investments77.9M22.0M116.3M123.2M141.7M148.8M
Good Will4.2M4.1M5.5M4.8M5.6M5.9M
Common Stock Shares Outstanding280.4M285.1M316.3M323.7M372.3M390.9M
Liabilities And Stockholders Equity157.8M109.8M255.4M398.3M458.0M480.9M
Non Current Liabilities Total58.8M69.7M89.8M92.0M105.8M111.1M
Inventory633K3.5M8.5M17.3M19.9M20.9M
Other Current Assets2.7M2.6M9.1M19.5M22.5M23.6M
Total Liab78.8M107.7M175.3M249.4M286.8M301.1M
Total Current Assets93.6M47.5M173.2M224.8M258.6M271.5M
Accumulated Other Comprehensive Income4.9M4.8M(18.2M)(33.7M)(30.3M)(28.8M)
Short Term Debt767K632K641K1.6M1.4M1.3M
Common Stock167.1M170.8M371.0M446.3M513.2M538.9M
Current Deferred Revenue174.6K7.1M19.3M63.2M72.6M76.3M
Retained Earnings(93.0M)(173.5M)(272.8M)(263.7M)(237.3M)(225.4M)
Non Currrent Assets Other183K212K327K586K527.4K501.0K
Net Receivables12.4M19.4M39.4M64.8M74.5M78.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Telix Stock Analysis

When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.